Browse the full record of transactions filed by Brumm Joshua T, Dirigeant. Insider active across 1 companies, notably Dyne Therapeutics, Inc.. Cumulatively, 8 disclosures have been logged. Total volume traded: €118k. The latest transaction was disclosed on 14 June 2022 — Disposition. Regulator: SEC (Form 4). The full history is free.
Joshua T. Brumm is an Executive at Dyne Therapeutics, Inc. He contributes to the strategic direction of the company, bringing his expertise in management and business development. His role is essential in supporting Dyne's mission and objectives.